Friday’s Midday Stock Update: Novavax (NVAX), Arrowhead Research (ARWR), Terra Tech Corp (TRTC), TG Therapeutics (TGTX), AFLAC Inc (AFL)

By Carrie Williams

So far Friday, January 12, NASDAQ is up 0.56% and the S&P is up 1.2%. Here are this morning’s most active stocks: Novavax (NASDAQ:NVAX), Arrowhead Research (NASDAQ:ARWR), Terra Tech Corp (Other OTC:TRTC), TG Therapeutics (NASDAQ:TGTX) and AFLAC Inc (NYSE:AFL).

Novavax is down -14.44% in midday trading to $1.66. Shares opened today at $1.94. The company has a 52-week low of $0.73 and a 52-week high of $2.14. On the Street’s front, the average 12-month analyst price target for the stock is $4.83, marking a 148.97% potential upside from current levels. In a report released yesterday, Ladenburg Thalmann analyst Kevin Degeeter reiterated a Buy rating on NVAX, with a price target of $2.50, which implies an upside of 29% from current levels. Separately, on December 19, Citigroup’s Joel Beatty downgraded the stock to Hold . Over the last 3 months, the insider sentiment on Novavax has been positive based on 13 corporate insider transactions. This sentiment is slightly higher than the average sector sentiment of insiders.

Arrowhead Research is up 11.99% in midday trading to $5.79. Shares opened today at $5.17. The company has a 52-week low of $1.42 and a 52-week high of $6.25. On the Street’s front, the average 12-month analyst price target for the stock is $2.5, marking a -51.64% potential downside from current levels. In a report issued on January 4, B.Riley FBR analyst Madhu Kumar assigned a Hold rating on ARWR, with a price target of $3, which implies a downside of 42% from current levels. Separately, on November 27, Piper Jaffray’s Edward Tenthoff upgraded the stock to Buy .

Terra Tech Corp is down -9.86% in midday trading to $0.28. Shares opened today at $0.31. The company has a 52-week low of $0.14 and a 52-week high of $0.63. In the last 30 days, insiders have sold $980.4K worth of TRTC shares. Over the last 3 months, the insider sentiment on Terra Tech Corp has been negative based on 11 corporate insider transactions. This sentiment is lower than the average sector sentiment of insiders.

TG Therapeutics is down -8.28% in midday trading to $9.68. Shares opened today at $10.55. The company has a 52-week low of $4.10 and a 52-week high of $15.35. On the Street’s front, the average 12-month analyst price target for the stock is $25.83, marking a 144.83% potential upside from current levels. In a report issued on January 8, H.C. Wainwright analyst Edward White assigned a Buy rating on TGTX, with a price target of $33, which implies an upside of 213% from current levels. In the last 30 days, insiders have sold $272.1K worth of TGTX shares. Over the last 3 months, the insider sentiment on TG Therapeutics has been negative based on 13 corporate insider transactions. This sentiment is lower than the average sector sentiment of insiders.

AFLAC Inc is down -7.58% in midday trading to $84.10. Shares opened today at $91.00. The company has a 52-week low of $66.50 and a 52-week high of $91.73. On the Street’s front, the average 12-month analyst price target for the stock is $86.71, marking a -4.71% potential downside from current levels. In a report issued on January 9, Wells Fargo analyst Sean Dargan reiterated a Hold rating on AFL, with a price target of $90, which represents a slight downside potential from current levels. Separately, on October 26, RBC’s Mark Dwelle reiterated a Sell rating on the stock and has a price target of $76. In the last 30 days, insiders have sold $881.4K worth of AFL shares. Over the last 3 months, the insider sentiment on AFLAC Inc has been negative based on 94 corporate insider transactions. This sentiment is lower than the average sector sentiment of insiders.